fentanyl NOL guided

PreclinicalSmall molecule

VVictor Contreras, MSN

fentanyl NOL guided is one of 20 small molecule programs targeting Intraoperative. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

IntraoperativeCompleted

IntraoperativePreclinical

Completed

Competition

Competitive Landscape

24 competitors in Intraoperative

#DrugCompanyPhaseTrials

Zofran

Novartis

Approved

1 2

IC-Green

PProvepharm SAS

Approved

8 3

Ketalar

AAultman Health Foundation

Approved

5 4

Anerem

AAcacia Pharma Ltd

Approved

2 5

Reglan

IIstituto Clinico Humanitas

Approved

1 6

Ciprofol

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

1 7

MS Contin

HHikma Pharmaceuticals LLC

Phase 2

1 8

Vancocin

HHikma Pharmaceuticals LLC

Phase 2

1 9

Marcaine

IInnocoll

Phase 2

1 10

Robinul

Jazz Pharmaceuticals

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Intraoperative1 trial

Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl

Completed·VVictor Contreras, MSN·N/A·NCT03858621·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for fentanyl NOL guided. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — fentanyl NOL guided compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for fentanyl NOL guided. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Victor Contreras, MSN company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: VVictor Contreras, MSN

fentanyl NOL guided

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Intraoperative1 trial

References

Drug Info

Quick Facts

Related News